Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).
Fervenza FC, Canetta PA, Barbour SJ, Lafayette RA, Rovin BH, Aslam N, Hladunewich MA, Irazabal MV, Sethi S, Gipson DS, Reich HN, Brenchley P, Kretzler M, Radhakrishnan J, Hebert LA, Gipson PE, Thomas LF, McCarthy ET, Appel GB, Jefferson JA, Eirin A, Lieske JC, Hogan MC, Greene EL, Dillon JJ, Leung N, Sedor JR, Rizk DV, Blumenthal SS, Lasic LB, Juncos LA, Green DF, Simon J, Sussman AN, Philibert D, Cattran DC; Mentor Consortium group. Fervenza FC, et al. Among authors: hladunewich ma. Nephron. 2015;130(3):159-68. doi: 10.1159/000430849. Epub 2015 Jun 12. Nephron. 2015. PMID: 26087670 Clinical Trial.
Pathophysiology of the clinical manifestations of preeclampsia.
Hladunewich M, Karumanchi SA, Lafayette R. Hladunewich M, et al. Clin J Am Soc Nephrol. 2007 May;2(3):543-9. doi: 10.2215/CJN.03761106. Epub 2007 Apr 4. Clin J Am Soc Nephrol. 2007. PMID: 17699462 Review. No abstract available.
Rituximab treatment of idiopathic membranous nephropathy.
Fervenza FC, Cosio FG, Erickson SB, Specks U, Herzenberg AM, Dillon JJ, Leung N, Cohen IM, Wochos DN, Bergstralh E, Hladunewich M, Cattran DC. Fervenza FC, et al. Kidney Int. 2008 Jan;73(1):117-25. doi: 10.1038/sj.ki.5002628. Epub 2007 Oct 17. Kidney Int. 2008. PMID: 17943078 Free article. Clinical Trial.
Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus.
Reich HN, Gladman DD, Urowitz MB, Bargman JM, Hladunewich MA, Lou W, Fan SC, Su J, Herzenberg AM, Cattran DC, Wither J, Landolt-Marticorena C, Scholey JW, Fortin PR. Reich HN, et al. Among authors: hladunewich ma. Kidney Int. 2011 Apr;79(8):914-20. doi: 10.1038/ki.2010.525. Epub 2011 Jan 19. Kidney Int. 2011. PMID: 21248713 Free article.
Validation of the Oxford classification of IgA nephropathy.
Herzenberg AM, Fogo AB, Reich HN, Troyanov S, Bavbek N, Massat AE, Hunley TE, Hladunewich MA, Julian BA, Fervenza FC, Cattran DC. Herzenberg AM, et al. Among authors: hladunewich ma. Kidney Int. 2011 Aug;80(3):310-7. doi: 10.1038/ki.2011.126. Epub 2011 May 4. Kidney Int. 2011. PMID: 21544062 Free article.
Venous thromboembolism in patients with membranous nephropathy.
Lionaki S, Derebail VK, Hogan SL, Barbour S, Lee T, Hladunewich M, Greenwald A, Hu Y, Jennette CE, Jennette JC, Falk RJ, Cattran DC, Nachman PH, Reich HN. Lionaki S, et al. Clin J Am Soc Nephrol. 2012 Jan;7(1):43-51. doi: 10.2215/CJN.04250511. Epub 2011 Nov 10. Clin J Am Soc Nephrol. 2012. PMID: 22076873 Free PMC article.
191 results